Whalesbook
The stock's climb followed a strong performance in the third quarter of fiscal year 2026. Zydus Wellness reported consolidated net sales of ₹963.3 crore, marking a significant 113.7 per cent year-on-year increase. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) also saw a dramatic rise, jumping 312.2 per cent year-on-year to ₹61.0 crore, reflecting strong operational efficiency and the positive impact of recent acquisitions.
The company's flagship brand, Sugar Free, further solidified its dominance in the sugar substitute market, capturing a 96.3 per cent market share. The 'D'lite' range expansion and consistent double-digit growth in Sugar Free Green contributed to this stellar performance, demonstrating sustained consumer demand and brand loyalty.
Analyst Optimism
Following the strong results, Motilal Oswal Financial Services reiterated its 'Buy' recommendation for Zydus Wellness. The brokerage firm set a target price of ₹575 per share, signaling an expectation of further upside. Motilal Oswal anticipates 8 per cent organic business revenue growth in the upcoming March 2026 quarter, primarily driven by volume increases.
The acquisition of ComfortClick in September 2025 is expected to continue bolstering consolidated revenue growth, while the RiteBite Max Protein range is projected to maintain its strong double-digit growth momentum. The firm also noted resilience in rural and urban demand across the broader consumer staple sector, despite marginal price hikes taken by companies to offset raw material inflation.